Flu vs. Flu: Last Year's Lessons, This Year's Strategy
Date:
December 4, 2019
Time:
2:30 PM ET
 
---------------------------------------
Webinar Description

---------------------------------------
215x300-FY'20-Q3-PC-12.png

Dr. John Tamerius
Senior Vice President for Strategic & External Affairs, Quidel
Dr. John Tamerius graduated from the Univ. of Washington (Seattle, Washington) with a Ph.D. in Microbiology and Immunology. He performed postdoctoral research in tumor immunology at the Fred Hutchinson Cancer Center (Seattle) before joining the Scripps Clinic and Research Foundation (San Diego) as a Research Associate in the Dept. of Molecular Immunology; here he studied inflammation and the complement system and was a National Arthritis Fellow. John joined Quidel Corporation in 1989. During his on-going tenure at Quidel he has held several important leadership roles, including VP of R&D, General Manager of Quidel’s northern California division, and SrVP of Clinical & Regulatory Affairs. Dr. Tamerius is an officer in Quidel and serves as Senior Vice President for Strategic & External Affairs. While head of R&D Dr. Tamerius was in charge of the development of the QuickVue Influenza A+B lateral flow test (approximately 85 million tests sold to date). More recently he was responsible for the clinical trials and FDA submissions that led to the FDA clearances and CLIA waivers for the immunofluorescence-based Sofia analyzer and the Sofia Influenza A+B Fluorescence Immunoassay (FIA), the Sofia RSV FIA, and the Sofia Strep A+ FIA. He also was responsible for the field studies leading to the validation of the Virena wireless communication and surveillance system.
---------------------------------------
Who Should Attend

Anyone who wants to be prepared for flu season.

 

---------------------------------------
Registration Form



 


Flu vs. Flu: Last Year's Lessons, This Year's Strategy
Date:
December 4, 2019
Time:
2:30 PM ET






Date:
December 4, 2019
Time:
2:30 PM ET
The Details
What can big flu data teach us about tracking trends and keeping your populations healthier? Join us to find out what the data says we can expect this year.
What You'll Learn
  • What state-by-state, week-by-week flu data showed us
  • Learn about the serious consequences of seniors skipping their flu shots
  • Discuss how to prepare now for the next flu season
  • Learn strategies to help you make a strong vaccine recommendation and help patients make informed decisions
 
Who is Speaking?
215x300-FY'20-Q3-PC-12.png
Dr. John Tamerius
Senior Vice President for Strategic & External Affairs, Quidel
Dr. John Tamerius graduated from the Univ. of Washington (Seattle, Washington) with a Ph.D. in Microbiology and Immunology. He performed postdoctoral research in tumor immunology at the Fred Hutchinson Cancer Center (Seattle) before joining the Scripps Clinic and Research Foundation (San Diego) as a Research Associate in the Dept. of Molecular Immunology; here he studied inflammation and the complement system and was a National Arthritis Fellow. John joined Quidel Corporation in 1989. During his on-going tenure at Quidel he has held several important leadership roles, including VP of R&D, General Manager of Quidel’s northern California division, and SrVP of Clinical & Regulatory Affairs. Dr. Tamerius is an officer in Quidel and serves as Senior Vice President for Strategic & External Affairs. While head of R&D Dr. Tamerius was in charge of the development of the QuickVue Influenza A+B lateral flow test (approximately 85 million tests sold to date). More recently he was responsible for the clinical trials and FDA submissions that led to the FDA clearances and CLIA waivers for the immunofluorescence-based Sofia analyzer and the Sofia Influenza A+B Fluorescence Immunoassay (FIA), the Sofia RSV FIA, and the Sofia Strep A+ FIA. He also was responsible for the field studies leading to the validation of the Virena wireless communication and surveillance system.
Who Should Join?

Anyone who wants to be prepared for flu season.

 
 
Webinar Description

About the Speaker
215x300-FY'20-Q3-PC-12.png
Dr. John Tamerius
Dr. John Tamerius graduated from the Univ. of Washington (Seattle, Washington) with a Ph.D. in Microbiology and Immunology. He performed postdoctoral research in tumor immunology at the Fred Hutchinson Cancer Center (Seattle) before joining the Scripps Clinic and Research Foundation (San Diego) as a Research Associate in the Dept. of Molecular Immunology; here he studied inflammation and the complement system and was a National Arthritis Fellow. John joined Quidel Corporation in 1989. During his on-going tenure at Quidel he has held several important leadership roles, including VP of R&D, General Manager of Quidel’s northern California division, and SrVP of Clinical & Regulatory Affairs. Dr. Tamerius is an officer in Quidel and serves as Senior Vice President for Strategic & External Affairs. While head of R&D Dr. Tamerius was in charge of the development of the QuickVue Influenza A+B lateral flow test (approximately 85 million tests sold to date). More recently he was responsible for the clinical trials and FDA submissions that led to the FDA clearances and CLIA waivers for the immunofluorescence-based Sofia analyzer and the Sofia Influenza A+B Fluorescence Immunoassay (FIA), the Sofia RSV FIA, and the Sofia Strep A+ FIA. He also was responsible for the field studies leading to the validation of the Virena wireless communication and surveillance system.

Who Should Attend

Anyone who wants to be prepared for flu season.

 
Save My Seat!

 

Registration Form

© 2019 McKesson Medical-Surgical Inc. All trademarks and registered trademarks are the property of their respective owners.

These webinars have been provided to participants on a complimentary basis. The content provided in these webinars and the related materials has been prepared, compiled or provided by the presenters and is not intended to constitute legal advice or the rendering of legal, consulting or other professional services of any kind. Any statements, positions and opinions expressed by the presenters do not necessarily reflect the statements, positions and opinions of McKesson. McKesson does not guarantee, warrant or otherwise endorse the products or services of any firm, organization or person connected with these webinars. McKesson is not responsible for, and makes no representations or warranties about, the accuracy or suitability of any information in the webinars and related materials; all such content is provided on an "as is" basis. MCKESSON HEREBY DISCLAIMS ALL WARRANTIES REGARDING THE CONTENT OF THESE MATERIALS.

McKesson makes no representations or warranties about, and disclaims all responsibility for, the accuracy or suitability of any information in the webinar and related materials; all such content is provided on an "as is" basis. MCKESSON FURTHER DISCLAIMS ALL WARRANTIES REGARDING THE CONTENTS OF THESE MATERIALS AND ANY PRODUCTS OR SERVICES DISCUSSED THEREIN, INCLUDING WITHOUT LIMITATION ALL WARRANTIES OF TITLE, NONINFRINGEMENT, MERCHANTABILITY, AND FITNESS FOR A PARTICULAR PURPOSE. The content of webinar and related materials should not be construed as legal advice and is intended solely for the use of a competent healthcare professional.

Eligibility Requirements for Participating in a McKesson Webinar: This webinar is not open to the general public. Your participation in this webinar cannot be transferred or assigned to anyone for any reason. You do not have to be a current customer of, purchase products from, or be affiliated with, McKesson, in order to participate in the webinars. McKesson, in its sole discretion, may terminate this promotion at any time. Due to certain regulatory restrictions, this promotion cannot be offered to health care providers licensed in Vermont and/or to government employees.

The information contained in this form, including coding information, reimbursement rates and potential revenue, was obtained from various sources. It is subject to change without notice and has not been independently verified by McKesson. The data and information are provided "as is" and you agree and acknowledge that neither McKesson nor any of its affiliates makes or gives any representation, warranty or endorsement with respect to any data or information in this document (including its reliability or accuracy) or the results that may be obtained from the use of the data or information, and there are no express or implied warranties, including, without limitation, implied warranties of non-infringement or title, merchantability, fitness for a particular use and fitness of information for any purpose. McKesson does not warrant or represent that any information or data provided to you will be complete or accurate, and you agree and acknowledge that McKesson shall have no liability with respect to or relating to any data or information provided hereunder, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.

Third party coverage and payment for medical products and services is affected by many factors. It is the provider's responsibility to determine appropriate coding for items and services provided. You should contact the appropriate third party payor for specific information on their coding and coverage policies and payment amounts.

McKesson is providing HCPCS/ CPT codes based upon information provided by the product manufacturers. McKesson does not make representations about the accuracy of this information. The HCPCS/ CPT codes do not indicate coverage or payment under any federal or state health care program. The entity that submits claims to any federal or state health care program has the responsibility to verify the accuracy of HCPCS/ CPT codes it submits for payment purposes.









Cold, cough and flu icon
Want to learn more about preventing cold, cough and flu during this busy season?     
                                                                        Learn More >